San Francisco, California, United States
We use human data and AI to develop better drugs faster.
- Revenue
- $98M
- Year founded
- 2015
- Team size
- 63
As of November 2026, Latka tracks 23 drug discovery software companies. They have combined revenues of $365M and employ 1.2K people. They have raised $714.4M and serve 55.2K customers combined.
Every company below sells drug discovery software to other businesses and is ranked by its most recent annual revenue. Revenue, funding, headcount and customer figures come from CEO interviews on the Latka podcast, public company filings, and Latka estimates where a company has not disclosed a number.
Drug Discovery Software encompasses a range of tools and applications that aid in the development of new pharmaceuticals. These solutions streamline the research process by enabling researchers to design, analyze, and optimize drug candidates more efficiently. Common use cases include target identification, lead optimization, and preclinical trials, wherein software facilitates simulations and predictions that guide decision-making during the drug discovery pipeline. Typically, drug discovery software features include molecular modeling, compound library management, virtual screening, and data analysis capabilities. Users of this software include pharmaceutical companies, biotech firms, and academic institutions focused on drug development. By automating complex processes, these tools help researchers reduce costs and timeframes associated with bringing new medicines to market.
Sorting: Highest -> Lowest
Showing 10 of 23 companies ranked by annual revenue.
San Francisco, California, United States
We use human data and AI to develop better drugs faster.
San Francisco, California, United States
insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients.
Berlin, Berlin, Germany
Aignostics is an AI-powered precision diagnostics company that focuses on pathology to assist with drug development and clinical research. It specializes in transforming drug development and improving patient outcomes with AI that delivers novel insights for precision medicine.
Glasgow, Scotland, United Kingdom
Chemify is a chemistry and chemical discovery digitization platform. It develops a digitization platform to run chemical code for drug discovery, chemical synthesis, and materials discovery.
San Francisco, California, United States
Provider of cloud-based data analytics platform designed to analyze omics datasets to understand the molecular basis of cellular phenotypes. The company's platform can process, analyze and visualize large omics data across metabolic, genomics, transcriptomics and proteomics among others and uses data analytics to transform decision making processes in research and development labs in biotechnology and pharmaceutical businesses, enabling scientists and doctors in biotech, pharma and hospitals to make real-time decisions.
San Francisco, California, United States
AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validation. Automating biotech R&D. About Optic Optic started as an AI research team developing high-performance similarity search algorithms. Today our proprietary AI-technology is powering products in multiple industries from blockchain to biotech.
London, England, United Kingdom
Developer of a cloud software platform designed to automate and improve the success rate of biological research and development. The company's platform uses artificial intelligence for designing and simulating biological systems, as well as methods of collating, structuring and analyzing experimental data, enabling clients to transfer biological designs into real 'wet lab' experiments via logistics simulation and execution seamlessly.
Cardiff, Wales, United Kingdom
Antiverse is a Welsh techbio company specializing in antibody design for challenging drug targets, utilizing advanced machine learning techniques to develop de novo antibody therapeutics.
Latka tracks 23 drug discovery software companies with reported revenue. Together they generate $365M in annual revenue and employ 1.2K people.
Verge Genomics is the largest, with $98M in annual revenue, founded in 2015.
The average drug discovery software company in this list makes $15.9M a year, across 23 companies with reported revenue. They serve 55.2K customers combined.
Ranked by annual revenue, the leaders are Verge Genomics, insitro, AIgnostics, Chemify Limited and Elucidata Corporation.
The 23 drug discovery software companies tracked here have raised $714.4M in disclosed funding between them.
- Offers tools for molecular modeling and simulations - Supports data analysis related to drug interactions and efficacy - Aids in target identification and validation in the drug discovery process - Includes features for library management of drug compounds - Must facilitate preclinical trial planning and analysis - Not just general research software; must specifically cater to drug discovery workflows